Olivier Elemento, Director of Englander Institute for Precision Medicine, shared an article by Junbum Kim, et al. on X:
“How do early lung tumors evolve?
Our latest preprint, led by Junbum Kim, maps early-stage cancer at single-cell resolution, revealing two key pathways:
- Driven by immune activity.
- Driven by fibrosis.
These insights could refine detection & treatment.”
Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression.
Authors: Junbum Kim, et al.
